The IAC Standards and Guidelines Superficial Venous Evaluation and Management |
Click here for a printer-friendly PDF of the Vein
Center Standards |
2.1C Facilities are required to have a process in place to
evaluate the QI measures outlined in sections 2.1.1C through 2.1.5C.
2.1.1C Procedure Appropriateness
2.1.1.1C The facility must evaluate the appropriateness of the
procedures performed and categorize as:
i. appropriate/usually appropriate;
ii. may be appropriate;
iii. rarely appropriate/usually not appropriate.
2.1.1.2C Appropriate
indications for the procedures must be measured for consecutive cases over a
time period which results in no less than 5% of the annual volume of cases.
i. For smaller
volume facilities, a minimum of 30 cases must be reviewed.
2.1.2C Technical Performance of the Procedure:
2.1.2.1C completeness of the procedure;
2.1.2.2C documentation of
adverse technical events such as equipment or device failure;
2.1.2.3C failure to perform the procedure;
2.1.2.4C quality of the diagnostic ultrasound;
2.1.2.5C reflux Doppler measurement;
2.1.2.6C diameter measurements;
2.1.2.7C adherence to the facility protocols.
2.1.3.1C Accuracy of
patient identification:
i. Use at least two
patient identifiers when providing care, treatment or services.
i. Label all
medication with name, concentration and expiration date.
ii. Premixed pharmacologic and/or anesthetic agents must be
labeled with content, concentration and expiration date if not prepared
immediately before use.
2.1.3.3C Infection control
measures consistent with CDC and OSHA guidelines.
2.1.3.4C Adherence to
National Patient Safety Goals must be documented.
2.1.4C Medical Record Completeness and Timeliness:
2.1.4.1C Time from completion
of procedure to signature of final documentation completed within two weeks.
2.1.5.1C The facility must
have a written policy and process to track and document the outcomes of all
patients evaluated and/or treated; this includes patients referred to a wound
care center.
2.1.5.2C Must document all
procedural outcomes in the
patient medical record.
2.1.5.3C Must document all adverse events that occur within (30
days) post-procedure in a centralized location or in retrievable electronic
medical records for review (download the Vein Center
Procedure Complications list at https://intersocietal.org/document/procedure-complication-list-vein-center);
2.1.5.4C Review of each case requiring referral outside the center for treatment
of complications.
(See
Guidelines below for further recommendations.)
Section 2C:
Quality Improvement Measures
Guidelines
2.1C Quality of
life measurement is encouraged.
Example of
vein-specific quality of life instruments include CIVIQ, VEINES Sym/QoL, the
Aberdeen Varicose Vein Score and the Specific Quality-of-life and Outcome
Response-Venous [SQOR-V]) questionnaire.